Navigation Links
Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia
Date:11/19/2008

-Triggers $5 Million Payment from Roche-

MONTVALE, N.J., Nov. 19 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals Corp. (Nasdaq: MEMY) today announced that it has achieved the enrollment goal for its Phase 2 trial of R3487/MEM 3454, its lead alpha-7 nicotinic receptor agonist, in cognitive impairment associated with schizophrenia (CIAS). The Company has randomized 212 patients in the Phase 2 trial, triggering a $5.0 million payment from its partner Roche. Memory Pharmaceuticals expects to report top-line results from the trial by the end of April 2009.

"This is the one of the first major studies evaluating a nicotinic alpha-7 receptor agonist in schizophrenia and we are pleased to have reached this important milestone for this program," stated Vaughn M. Kailian, President and Chief Executive Officer of Memory Pharmaceuticals. "We are focused on completing this trial and look forward to releasing the study results regarding the potential of R3487/MEM 3454 to address the cognitive deficits associated with the disorder."

The trial is designed to include approximately 212 patients with stable schizophrenia who are receiving atypical antipsychotic therapy. Subjects in the study are randomized to receive 5 mg, 15 mg or 50 mg of R3487/MEM 3454 or placebo once daily for a period of eight weeks. The primary objective of the trial is to assess the effectiveness of R3487/MEM 3454 in CIAS using the MATRICS Consensus Cognitive Battery (MCCB). Secondary objectives include assessing the effectiveness of the drug to improve other symptoms of schizophrenia and functional capacity.

R3487/MEM 3454 is being developed in partnership with Roche. Under the terms of the agreement, a payment from Roche to the Company of $8.5 million will become due 30 days after the availability of top-line data from th
'/>"/>

SOURCE Memory Pharmaceuticals Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Memory Pharmaceuticals and Roche Expand R3487/MEM 3454 Development Program
2. Study Suggests a Possible Way to Offset Chemobrain Memory Loss
3. Alzheimers Foundation of America Survey: Americans With Memory Concerns Fall Short of Talking to Doctors
4. Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day
5. Roche Exercises its Option to Further Develop and Commercialize Memory Pharmaceuticals Nicotinic Alpha-7 Agonist, MEM 3454
6. Medivations Dimebon(TM) Significantly Improved Thinking and Memory in Alzheimers Disease Patients Over One Year
7. How Big Is Your Brain? Its Size May Protect You from Memory Loss
8. Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2007 Financial Results
9. Memory Pharmaceuticals & Roche Expand Development Program for MEM 3454 in Schizophrenia
10. Experts Call for Widespread Use of Memory Screenings and Emphasize Value of Early Detection of Dementia
11. Memory Pharmaceuticals Announces Results for Phase 2a Trial of MEM 1003 in Alzheimers Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Research and Markets( ... "Veterinary / Animal Vaccines Market by Product, Diseases & ... their offering. The global animal vaccines market ... $5,507.3 Million in 2015, at a CAGR of 5.5% ... market growth are growing prevalence of animal diseases, increasing ...
(Date:7/2/2015)... 2015   Wilson Therapeutics AB , a privately-held ... to its board of directors. The appointment was approved ... June 30. "We are delighted to welcome ... Hansson , CEO of Wilson Therapeutics. "Hans brings significant ... forward to his contributions to the Company." ...
(Date:7/1/2015)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today ... at the Cantor Fitzgerald Healthcare Conference in New ... Russell Cox , executive vice president and chief operating officer, ... and financial update on Wednesday, July 8, 2015 at 9:30 ... live audio webcast of the presentation may be accessed from ...
Breaking Medicine Technology:Veterinary / Animal Vaccines Market 2015 - Global Forecast to 2020 for the $7.19 Billion Industry 2Wilson Therapeutics Appoints Hans Schikan to its Board of Directors 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2
... helps researchers utilize bioinformatics tools Elsevier ... information products and services, today announced the availability of ... . Created by OpenHelix , the application enables ... genomics resources and tools used or cited in an ...
... Mass. and TORONTO, Jan. 17, 2012  Generex Biotechnology ... interview conducted at the BioTech Showcase 2012 during ... with Dr. Eric von Hofe, Ph.D., President of ... Express breast cancer vaccine, is available on the ...
Cached Medicine Technology:Elsevier and OpenHelix Release Tutorial Suites for SciVerse Applications 2Elsevier and OpenHelix Release Tutorial Suites for SciVerse Applications 3Elsevier and OpenHelix Release Tutorial Suites for SciVerse Applications 4Generex Subsidiary Antigen Express Featured on SNN Stock News Now; Highlights Advantages of Ii-Key Platform Technology for Cancer Immunotherapy 2Generex Subsidiary Antigen Express Featured on SNN Stock News Now; Highlights Advantages of Ii-Key Platform Technology for Cancer Immunotherapy 3Generex Subsidiary Antigen Express Featured on SNN Stock News Now; Highlights Advantages of Ii-Key Platform Technology for Cancer Immunotherapy 4Generex Subsidiary Antigen Express Featured on SNN Stock News Now; Highlights Advantages of Ii-Key Platform Technology for Cancer Immunotherapy 5
(Date:7/3/2015)... ... 2015 , ... " Selfie on a Stick ” was featured on NewsWatch ... products available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, ... documenting memories. , Almost every smartphone has an incredibly powerful camera built into it. ...
(Date:7/2/2015)... ... July 02, 2015 , ... sweetFrog Enterprises, LLC. is pleased to announce the opening ... located in the Lone Star State. The premium frozen yogurt chain was listed as #22 ... opened June 19 in the Village at Bachman Lake, is located at:, 3701 W. Northwest ...
(Date:7/2/2015)... (PRWEB) , ... July 02, 2015 , ... Many Fourth ... in mind. That’s why Amica Insurance is sharing some tips to promote ... (CPSC), approximately 230 people go to the emergency room daily with fireworks-related injuries in ...
(Date:7/2/2015)... ... July 02, 2015 , ... Get ... the SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have rapidly ... significant popularity has inspired four new, fun shades including: blue, lime, pink and ...
(Date:7/2/2015)... ... July 02, 2015 , ... When ... met for the late June Web-based session, the speakers discussed the importance of ... managing high-risk patients through coordinated care. , During the session, participants learned the ...
Breaking Medicine News(10 mins):Health News:Learn How to Take Selfies like Kendall Jenner 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4
... American men could be putting their health at risk ... results might threaten their masculinity. Because they prove their ... advice including HIV/AIDS testing goes against their notion of ... Department of Sociology at Yale University in the US, ...
... could lead to better therapies for severe forms of the ... the University of Texas Southwestern Medical Center have figured what ... when he or she has a severe staph infection. , ... infections but applicable to all people, could lead to ...
... 21 /PRNewswire-FirstCall/ - Hard to Treat Diseases (HTDS.PK) ... registration of MEVAC-A for the country of Thailand. The ... quarter of 2009. , This registration is required to ... in is Mellow Hope products such as MEVAC-A, MEVAC-DTaP, ...
... In the past decade the popularity of rock climbing has ... now enjoyed by more than 9 million people in the ... Center for Injury Research and Policy of the Research Institute ... of the sport has escalated, so have the number of ...
... , , NEW YORK, July 21 ... (SSW) is expanding its ranks with the hire of Ned Russell as EVP, ... a member of the agency,s Executive Team. , , ... sides of the marketing business. Most recently he was VP of Brand Marketing ...
... , MINNEAPOLIS, July 21 /PRNewswire-USNewswire / -- ... convened today in Minneapolis, MN to honor the 2009 ... the National Alliance for Caregiving and MetLife Foundation. The ... adults, rewarding innovation, effectiveness, and responsiveness to caregiver needs. ...
Cached Medicine News:Health News:'Go to the doctor? Only if I'm really sick ...' 2Health News:Immune System Gene Discovery Sheds Light on Staph Infections 2Health News:Hard To Treat Diseases (HTDS.PK) Thailand Registration 2Health News:First national study to examine rock climbing-related injuries 2Health News:Ned Russell Joins Saatchi & Saatchi Wellness 2Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 2Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 3Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 4Health News:The National Alliance for Caregiving and MetLife Foundation Honor Innovators Making a Difference in the Lives of Caregivers 5
Its MicroPoint design and reference marks at 10, 50 and 100 L ensure accurate performance with a variety of multi-channel and single-channel pipettors....
... tip, the Finntip Wide is designed especially ... like genomic DNA. This tip eliminates the ... is excellent for use with extremely viscous ... diameter of the orifice is 1.1 mm ...
For plaque coring...
Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels...
Medicine Products: